Show simple item record

dc.contributor.authorShankar, R
dc.contributor.authorRowe, C
dc.contributor.authorVan Hoorne, A
dc.contributor.authorHenley, W
dc.contributor.authorLaugharne, R
dc.contributor.authorCox, D
dc.contributor.authorPande, R
dc.contributor.authorRoy, A
dc.contributor.authorSander, JW
dc.date.accessioned2018-06-28T10:43:43Z
dc.date.issued2018-06-21
dc.description.abstractPurpose One quarter of people with epilepsy have an intellectual disability (ID) and one fifth of people with an ID have epilepsy. Both conditions are associated with higher levels of morbidity, stigma and premature mortality. There have been calls for action to promote more research in this group. We examined if this group are represented adequately in current research. Methods The proportion of research output in epilepsy conferences and publications relevant to ID and the proportion in ID conferences and publications on epilepsy for 2015–2016 were identified. As the percentage of children in the population with epilepsy is 17%, research output of this group was compared with the ID group. Recognised material was classified based on whether it applied to general epilepsy/ID research, children with epilepsy or people with epilepsy and ID. Data was analysed to determine the proportion of presented research specifically identifying people with epilepsy and ID. Results Fewer than 2% of presentations at epilepsy conferences specifically related to the ID and epilepsy group compared to 15% relating to children with epilepsy. Similarly only 1.4% of the research presented at major ID conferences related to those with people with epilepsy and ID. About 5% of published research in the field of epilepsy related to those with ID as compared with 24% for children with epilepsy. Twelve percent of published research in ID specifically identified epilepsy. Conclusion Publications and conference presentations, on the population with epilepsy and comorbid ID is under-represented. Increased research in this area might assist in improving the quality of care for this relatively neglected group.en_GB
dc.description.sponsorshipJWS has received departmental research support from GSK, Eisai Co. and UCB Pharma. RS has received research support from UCB, Eisai Co., Special Products, LivaNova and Desitin.en_GB
dc.identifier.citationVol. 13 (6), article e0198261en_GB
dc.identifier.doi10.1371/journal.pone.0198261
dc.identifier.urihttp://hdl.handle.net/10871/33316
dc.language.isoenen_GB
dc.publisherPublic Library of Scienceen_GB
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pubmed/29927966en_GB
dc.rights© 2018 Shankar et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.en_GB
dc.titleUnder representation of people with epilepsy and intellectual disability in research.en_GB
dc.typeArticleen_GB
dc.date.available2018-06-28T10:43:43Z
dc.identifier.issn1932-6203
dc.descriptionThis is the final published version.en_GB
dc.descriptionAvailable from PLoS via the DOI in this record.en_GB
dc.identifier.journalPLoS Oneen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record